abnormal blood coagulation_Cpb2<tm1Mng>/Cpb2<tm1Mng>

http://metadb.riken.jp/0002551I129S1Sv129X1SvJC57BL6Cpb2tm1MngCpb2tm1MngCpb2tm1Mng

abnormal blood coagulation_Cpb2<tm1Mng>/Cpb2<tm1Mng>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• carboxypeptidase B2 (plasma)
  http://metadb.riken.jp/db/mgi_rdf/MGI:1891837

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cpb2<tm1Mng>/Cpb2<tm1Mng>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cpb2<tm1Mng>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal blood coagulation
  http://purl.obolibrary.org/obo/MP_0002551

文献

http://purl.org/net/cito/citesAsAuthority

• Mariko. Nagashima, et.al., Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life., The Journal of clinical investigation, 2002, 109
  http://rdf.ncbi.nlm.nih.gov/pubmed/11781355
• Hajime. Fujimoto, et.al., Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis., The American journal of pathology, 2006, 168
  http://rdf.ncbi.nlm.nih.gov/pubmed/16565485